# Performance Optimization Strategy Specification #18 — Section 9: Approval Checklist

**Created:** May 13, 2026
**Last Updated:** May 15, 2026 (v1.0 APPROVED — `TBD-NORMATIVE` sweep complete; lead-developer sign-off granted)
**Purpose:** Self-applicable approval checklist. Every row resolves
to either a named, version-controlled file path or a named programmatic
check (per Spec #19 KD-6 programmatic-verification mandate). Rows
binding `[GT]` governance numbers cite the section-file path verbatim
per the §3.10 / §8.4 evidence-artifact convention.

---

## 9.1 Content Checklist

- [x] All required sections present, including template-slot
      reconciliations:
  - §5 reflexive Test Plan (parallel to Spec #19 §5).
  - §6 CI Orchestration Policy & Triage (replaces template "Performance
    Analysis" — parallel to Spec #19 §6).
  - Evidence: `section-1.md`, `section-2.md`, `section-3.md`,
    `section-4.md`, `section-5.md`, `section-6.md`, `section-7.md`,
    `section-8.md`, `section-9-approval-checklist.md`, `appendices.md`
    all present in `docs/specs/performance-optimization/`.
- [x] All FR-PO-### present in §2.2 with conformance level, source
      citation, verification pointer (§5.x), and activation stage.
  - Evidence: `section-2.md §2.2` rows; 82 FRs total (FR-PO-001 …
    FR-PO-080 + FR-PO-019a + FR-PO-058a).
- [x] KD-1 … KD-11 each codified in at least one §3 / §5 / §6
      subsection.
  - Evidence: `section-1.md §1.3` codification map.
- [x] Boundary statements with #16 §5 / §3.2.4.1 / §3.1 (KD-3 inverted),
      #19 §6 (KD-4), and every per-spec §6 (KD-2) explicit.
  - Evidence: `section-3.md §3.5.3`, `section-3.md §3.8`, `section-5.md
    §5.7`, `section-6.md §6.3`.

## 9.2 Quality Checklist

- [x] Cite-not-redefine rule audited (no restatements of #16, #19,
      #20, or per-spec §6 rules).
  - Evidence: §5.3 auditor KD-1 pass output (Stage 0: manual review
    notes).
- [x] Every FR row in §2.2 resolves to a §5.x verification mechanism.
  - Evidence: `section-2.md §2.2` "Verify" column; `section-5.md
    §5.6` traceability table.
- [x] Every approval-checklist row in *this* checklist cites either a
      file path or a check name (Spec #19 KD-6 self-application via
      Spec #19 §3.5.1, `TBD-NORMATIVE`).
  - Evidence: every row of §9.1 / §9.2 / §9.3 carries an "Evidence:"
    sub-bullet.
- [x] All cross-references (XC- / FM- / EC- / ERR-) resolve.
  - Evidence: grep against `docs/specs/` for unresolved IDs (manual
    Stage 0; programmatic Stage 0+1).
- [x] Per-spec §6 schema (Appendix B) present and complete.
  - Evidence: `appendices.md` Appendix B paste-ready template.
- [x] All `TBD-NORMATIVE`-tagged citations of #16 (KD-3) and #19
      (KD-4) enumerated; outstanding tags listed for the reviewer.
  - Evidence: §8.1.2 (Spec #16 register) and §8.1.3 (Spec #19
    register); both flagged "Status: IN PROGRESS / IN REVIEW" with
    blanket `TBD-NORMATIVE` per status caveat.
- [x] **Appendix D survey is NOT a #18-approval gate.** The survey of
      #1–#8 / #17 §6 sections is a Stage 0+1 deliverable (§7.2); for
      #18's own approval the requirement is only that Appendix D
      exists with the schema and an empty / partial table. Completing
      the survey rows is deferred so #18's approval is not converted
      into a 9-spec audit task. Parallel to Spec #19 Appendix D scope
      decision.
  - Evidence: `appendices.md` Appendix D headers present; table body
    empty/partial.
- [x] Governance-number evidence-artifact citations (per §3.10 / §8.4)
      verified — for each `[GT]` value, the cited section-file path
      contains the literal number claimed.
  - Evidence: `section-8.md §8.4` table; auditor confirms literal
    presence at each cited path.

## 9.3 Review Checklist

- [x] Open issues logged in `CLAUDE.md` "OPEN ISSUES" if any.
  - Evidence: post-draft sweep of `CLAUDE.md` — entry for Spec #18
    transition `IN PROGRESS → IN REVIEW` added.
- [x] Lead-developer sign-off captured.
  - Evidence: sign-off note appended to §9.4 "Decision" block and to
    `CLAUDE.md` OPEN ISSUES entry.
- [x] `spec-error-log.md` updated with any cross-spec drift discovered
      during drafting (ERR-018-NNN rows for any per-spec §6 schema
      gaps found).
  - Evidence: `docs/tracking/spec-error-log.md` rows; `ERR-018-001`
    closed atomically with this section file's landing.
- [x] `SPEC_INDEX.md` status updated atomically with the
      `IN PROGRESS → IN REVIEW` flip (landed v0.2 fix pass, May 14, 2026
      — recorded here for traceability; final sign-off completes the
      `IN REVIEW → APPROVED` flip atomically). Checkbox kept `[ ]`
      until §9.4 sign-off lands.
  - Evidence: `docs/specs/SPEC_INDEX.md` row 18 status field (`IN
    REVIEW` as of May 14, 2026).
- [x] Spec #19's `TBD-NORMATIVE` tags pointing at "Spec #18 §4 / §7"
      preconditions (per Spec #19 KD-3 status caveat) audited: those
      preconditions are this file set (§4 + §7 headers present) —
      confirm #19 reviewer is aware that #18 advancement past `IN
      REVIEW` is symmetric with #18 advancing toward `APPROVED`.
  - Evidence: `testing-strategy/section-1.md §1.4` bidirectional
    sequencing block; #19 reviewer note.
- [x] `docs/tracking/file-manifest.md` updated to reflect new
      section-file content. Tracking-document updates land atomically
      with the v0.x fix pass; checkbox kept `[ ]` until §9.4 sign-off.
  - Evidence: `file-manifest.md` row 18 records "v0.3 (PASS-2
    adversarial review `ERR-018-012` … `ERR-018-018` resolved May 14,
    2026)" — moved from "v0.2" to "drafted at v0.3".

## 9.4 Decision

- **Status:** **`APPROVED`** (May 15, 2026; lead-developer sign-off granted). All §9.1 / §9.2 / §9.3 rows resolved. KD-2 sequencing satisfied: #16 Tier 2 `APPROVED` May 14; #19 `APPROVED` May 15 (later same day); #18 `[TBD-NORMATIVE]` sweep landed in v1.0 patch May 15 (all citations to #16 and #19 now firm); §9.4.1 blockers all resolved. `SPEC_INDEX.md` row 18 updated atomically.
- **Historical status:** `IN REVIEW` (author-driven flip May 14, 2026 with v0.2 fix pass; lead-developer review subsequently completed).
- **Approval evidence:** file paths to programmatically-verifiable
  sources (KD-6 self-application — every row above must comply).
- **Evidence-artifact convention for `[GT]` governance numbers**
  (parallel to Spec #19 §9.4 L5 convention). Per §3.10 / §8.4, each
  governance number's evidence is the section-file citation that
  publishes the number (e.g., `section-3.md §3.5.2` for the +5%
  threshold). Checklist rows pointing at `[GT]` numbers MUST cite the
  section-file path verbatim; the §5.3 auditor (or Spec #19 §5.3
  checklist auditor under #19 KD-6) confirms the literal number is
  present at that path.

### 9.4.1 `TBD-NORMATIVE` Blockers — All Resolved May 15, 2026

Listed here for the reviewer (historical record of the resolution cycle):

- **Spec #16 citations** — RESOLVED. #16 reached Tier 2 `APPROVED` May 14, 2026; all #16 citations in §3.3.2 / §3.3.3 / §3.5.3 / §3.6.1 / §3.8.1 / §3.8.3 / §3.8.4 / §4.2 / §5.7.1 / §8.1.2 swept against final APPROVED text in v1.0 patch (May 15, 2026).
- **Spec #19 citations** — RESOLVED. #19 reached `APPROVED` May 15, 2026; all #19 citations in §3.3.5 / §3.4.3 / §3.5.3 / §3.9.5 / §4.3.1 / §4.4 / §5.7.2 / §6.1 / §6.3 / §8.1.3 swept against #19 v1.0.1 patch-revised text in v1.0 patch (May 15, 2026).
- **`certification-platform.md` Stage 0 row `_TBD_`** — NOT a #18-approval blocker per KD-9 status caveat. Remains a lead-developer task tracked in CLAUDE.md OPEN ISSUES; blocks first `FR-PO-052` Stage 0+1 perf-gate activation only.

Resolution path executed (per §1.4 bidirectional sequencing):
1. ✅ #18 reached `IN REVIEW` (v0.2 fix pass, May 14, 2026).
2. ✅ #16 reached Tier 2 `APPROVED` (May 14, 2026, later same day) — unlocked #16 `TBD-NORMATIVE` tags.
3. ✅ #19 reached `APPROVED` (May 15, 2026, later same day) — unlocked #19 `TBD-NORMATIVE` tags.
4. ✅ #18 `TBD-NORMATIVE` tags swept (May 15, 2026, v1.0 patch); #18 advanced `IN REVIEW → APPROVED`.

## 9.5 Version History

| Version | Date         | Author      | Notes |
|---------|--------------|-------------|-------|
| 0.3     | May 14, 2026 | Claude Code | PASS-2 adversarial-review fix pass (`ERR-018-014`, L-3). Duplicate v0.2 version-history row consolidated. §9.3 `[x]` checkboxes for SPEC_INDEX.md and file-manifest.md reverted to `[ ]` with note — convention is checkboxes flip `[x]` atomically at §9.4 lead-developer sign-off, not as pre-tracking. §9.1 FR count evidence updated 81 → 82 (FR-PO-019 split into FR-PO-019 + FR-PO-019a per `ERR-018-017`). §9.3 file-manifest evidence updated to reflect v0.3. |
| 1.0     | May 15, 2026 | Claude Code | **APPROVED.** v1.0 `[TBD-NORMATIVE]` sweep landed across §1 / §2 / §3 / §4 / §5 / §6 / §8 / appendices — 60 citation-qualifier instances resolved against #16 APPROVED (Tier 2) text and #19 v1.0.1 patch-revised text. All §9.1 / §9.2 / §9.3 boxes ticked; §9.4.1 blockers all marked RESOLVED; §9.4 Decision block updated to APPROVED. KD-2 sequencing satisfied. SPEC_INDEX.md row 18 IN REVIEW → APPROVED. Lead-developer sign-off granted. |
| 0.1     | May 13, 2026 | Claude Code | Initial draft from `outline-detailed.md` v1.1 §9. Self-applicable checklist with KD-6 binding (every row cites file path or programmatic check). Appendix D survey scope decision recorded. `TBD-NORMATIVE` blocker list at §9.4.1 explicit for reviewer. Status flipped to `IN REVIEW` author-driven; lead-developer sign-off pending. |
| 0.2     | May 14, 2026 | Claude Code | PASS-1 adversarial-review fix pass (`ERR-018-007` / 011). §9.4.1 #19 blocker list extended to include §3.3.5, §3.4.3, §3.9.5 (now `TBD-NORMATIVE`). §9.3 atomic-update checkbox flipped `[x]` for the `IN PROGRESS → IN REVIEW` flip (now atomic with `SPEC_INDEX.md` row 18 update); §9.3 file-manifest checkbox also flipped `[x]` (manifest updated to record v0.2). `IN REVIEW → APPROVED` flip remains the future atomic update with lead-developer sign-off. |
